KLAC · Kla Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.42B | $3.30B | $3.21B | $3.08B | $3.06B | $2.84B | $2.49B | $2.36B | $2.40B | $2.98B |
| Cost of Revenue | $1.33B | $1.27B | $1.24B | $1.22B | $1.18B | $1.15B | $976.75M | $993.88M | $946.89M | $1.21B |
| Gross Profit | $2.09B | $2.03B | $1.97B | $1.86B | $1.89B | $1.69B | $1.51B | $1.37B | $1.45B | $1.78B |
| R&D | $388.76M | $383.87M | $360.46M | $346.16M | $338.04M | $323.14M | $320.42M | $321.59M | $311.21M | $332.83M |
| SG&A | $291.13M | $279.92M | $268.99M | $267.08M | $248.91M | $251.04M | $237.24M | $237.51M | $239.65M | $243.10M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | $97.02M | - | - | $95.82M | - | - | $102.40M | - |
| Operating Income | $1.42B | $1.33B | $1.31B | $972.53M | $1.26B | $1.08B | $691.27M | $702.01M | $851.71M | $1.14B |
| Interest Expense | $70.42M | $69.67M | $71.08M | $74.20M | $79.98M | $82.17M | $74.20M | $79.98M | $74.23M | $74.28M |
| Income Tax | $215.77M | $184.62M | $188.44M | $148.00M | $176.02M | $132.84M | $108.74M | $100.47M | $110.34M | $164.18M |
| Net Income | $1.20B | $1.15B | $1.12B | $824.53M | $1.09B | $945.85M | $582.53M | $601.54M | $741.38M | $978.79M |
| EPS - Basic | $9.17 | $8.73 | $8.51 | $6.18 | $8.21 | $7.05 | $4.30 | $4.46 | $5.43 | $6.93 |
| EPS - Diluted | $9.12 | $8.68 | $8.47 | $6.16 | $8.16 | $7.01 | $4.28 | $4.43 | $5.41 | $6.89 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.79B | $2.45B | $1.95B | $2.08B | $1.86B | $1.98B | $1.98B | $1.85B | $1.71B | $1.93B |
| Accounts Receivable | $2.30B | $2.07B | $2.28B | $2.26B | $2.16B | $1.95B | $1.83B | $1.63B | $1.63B | $1.75B |
| Inventory | $3.44B | $3.28B | $3.30B | $3.21B | $3.16B | $3.11B | $3.03B | $3.01B | $3.01B | $2.88B |
| Accounts Payable | $515.01M | $425.19M | $429.84M | $458.51M | $429.32M | $376.50M | $359.49M | $354.72M | $363.66M | $371.03M |
| Current Assets | $11.35B | $11.26B | $10.90B | $10.70B | $9.95B | $10.23B | $10.03B | $9.53B | $8.43B | $8.37B |
| Total Assets | $16.87B | $16.72B | $16.32B | $16.07B | $15.19B | $15.68B | $15.43B | $14.96B | $14.14B | $14.07B |
| Current Liabilities | $3.75B | $3.98B | $4.05B | $4.09B | $3.91B | $4.80B | $4.66B | $4.46B | $3.82B | $3.74B |
| Long-term Debt | $5.89B | $5.89B | $5.89B | $5.88B | $5.88B | $5.88B | $5.88B | $5.88B | $5.89B | $5.89B |
| Total Liabilities | $11.04B | $11.25B | $11.33B | $11.38B | $11.18B | $12.12B | $12.07B | $11.86B | $11.15B | $11.15B |
| Stockholders' Equity | $5.83B | $5.47B | $4.99B | $4.69B | $4.00B | $3.56B | $3.37B | $3.09B | $2.99B | $2.92B |
| Retained Earnings | $3.19B | $2.86B | $2.50B | $2.18B | $1.65B | $1.33B | $1.14B | $958.90M | $966.18M | $848.43M |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $1.16B | - | - | $995.24M | - | - | $883.74M | - |
| Investing Cash Flow | - | - | ($409.99M) | - | - | ($171.04M) | - | - | ($391.67M) | - |
| Financing Cash Flow | - | - | ($881.80M) | - | - | ($837.71M) | - | - | ($705.16M) | - |
| CapEx | - | - | $95.89M | - | - | $60.39M | - | - | $68.05M | - |
| Free Cash Flow | - | - | $1.07B | - | - | $934.85M | - | - | $815.70M | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 61.1% | 61.4% | 61.3% | 60.3% | 61.6% | 59.6% | 60.7% | 57.9% | 60.5% | 59.5% |
| Operating margin | 41.5% | 40.3% | 40.8% | 31.6% | 41.3% | 38.0% | 27.8% | 29.7% | 35.5% | 38.3% |
| EBITDA margin | - | - | 43.8% | - | - | 41.3% | - | - | 39.8% | - |
| Net margin | 35.2% | 34.7% | 34.9% | 26.8% | 35.5% | 33.3% | 23.4% | 25.5% | 30.9% | 32.8% |
| Free cash flow margin | - | - | 33.2% | - | - | 32.9% | - | - | 34.0% | - |
| FCF / Net income | - | - | 0.95 | - | - | 0.99 | - | - | 1.10 | - |
| R&D / Revenue | 11.4% | 11.6% | 11.2% | 11.3% | 11.0% | 11.4% | 12.9% | 13.6% | 13.0% | 11.2% |
| SG&A / Revenue | 8.5% | 8.5% | 8.4% | 8.7% | 8.1% | 8.8% | 9.5% | 10.1% | 10.0% | 8.1% |
| Effective tax rate | 15.2% | 13.9% | 14.4% | 15.2% | 13.9% | 12.3% | 15.7% | 14.3% | 13.0% | 14.4% |
| Return on assets | 7.1% | 6.9% | 6.9% | 5.1% | 7.2% | 6.0% | 3.8% | 4.0% | 5.2% | 7.0% |
| Return on equity | 20.6% | 21.0% | 22.5% | 17.6% | 27.2% | 26.6% | 17.3% | 19.4% | 24.8% | 33.5% |
| Return on invested capital | 10.2% | 10.1% | 10.3% | 7.8% | 11.0% | 10.0% | 6.3% | 6.7% | 8.3% | 11.1% |
| Liquidity | ||||||||||
| Current ratio | 3.03 | 2.83 | 2.69 | 2.62 | 2.54 | 2.13 | 2.15 | 2.14 | 2.21 | 2.24 |
| Quick ratio | 2.11 | 2.00 | 1.88 | 1.83 | 1.74 | 1.48 | 1.50 | 1.46 | 1.42 | 1.47 |
| Cash ratio | 0.48 | 0.62 | 0.48 | 0.51 | 0.48 | 0.41 | 0.42 | 0.41 | 0.45 | 0.52 |
| Leverage | ||||||||||
| Debt / Equity | 1.01 | 1.08 | 1.18 | 1.25 | 1.47 | 1.65 | 1.75 | 1.90 | 1.97 | 2.02 |
| Debt / Assets | 0.35 | 0.35 | 0.36 | 0.37 | 0.39 | 0.38 | 0.38 | 0.39 | 0.42 | 0.42 |
| Debt / EBITDA | - | - | 4.18 | - | - | 5.01 | - | - | 6.18 | - |
| Interest coverage | 20.1x | 19.1x | 18.4x | 13.1x | 15.8x | 13.1x | 9.3x | 8.8x | 11.5x | 15.4x |
| Equity multiplier | 2.89 | 3.06 | 3.27 | 3.42 | 3.79 | 4.41 | 4.58 | 4.83 | 4.73 | 4.82 |
| Liabilities / Assets | 0.65 | 0.67 | 0.69 | 0.71 | 0.74 | 0.77 | 0.78 | 0.79 | 0.79 | 0.79 |
| Efficiency | ||||||||||
| Asset turnover | 0.20 | 0.20 | 0.20 | 0.19 | 0.20 | 0.18 | 0.16 | 0.16 | 0.17 | 0.21 |
| Inventory turnover | 0.39 | 0.39 | 0.38 | 0.38 | 0.37 | 0.37 | 0.32 | 0.33 | 0.31 | 0.42 |
| Days sales outstanding | 246d | 230d | 259d | 269d | 257d | 251d | 269d | 251d | 248d | 214d |
| Days inventory outstanding | 945d | 943d | 968d | 960d | 980d | 989d | 1134d | 1104d | 1159d | 869d |
| Days payable outstanding | 142d | 122d | 126d | 137d | 133d | 120d | 134d | 130d | 140d | 112d |
| Cash conversion cycle | 1050d | 1050d | 1101d | 1091d | 1104d | 1120d | 1269d | 1225d | 1268d | 971d |
| Valuation | ||||||||||
| P / E | 161.4x | 140.0x | 127.3x | 145.4x | 83.3x | 110.5x | 192.6x | 157.7x | 84.8x | 70.4x |
| P / B | 33.3x | 29.3x | 28.6x | 25.6x | 22.6x | 29.3x | 33.4x | 30.7x | 21.0x | 23.6x |
| P / S | 56.8x | 48.6x | 44.5x | 39.0x | 29.6x | 36.8x | 45.2x | 40.2x | 26.2x | 23.1x |
| EV / EBITDA | - | - | 104.3x | - | - | 92.2x | - | - | 70.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 11.5% | 7.2% | 13.0% | 23.7% | 29.8% | 18.5% | -16.7% | -3.0% | -12.0% | 26.8% |
| Revenue CAGR (3y) | 12.0% | 3.4% | 5.6% | 9.4% | 10.2% | 10.9% | 14.6% | 9.4% | 15.9% | 25.5% |
| Revenue CAGR (5y) | 13.6% | 14.8% | 15.8% | 15.3% | 16.6% | 15.0% | 20.6% | 16.5% | 17.0% | 25.0% |
| Gross profit growth (YoY) | 10.6% | 9.2% | 16.1% | 22.9% | 38.2% | 16.8% | -14.9% | -4.3% | -13.9% | 22.9% |
| Operating income growth (YoY) | 12.0% | 36.8% | 21.4% | 40.7% | 80.1% | 26.6% | -39.5% | -12.3% | -20.4% | 116.7% |
| Net income growth (YoY) | 10.3% | 39.0% | 18.5% | 41.5% | 80.9% | 27.6% | -40.5% | -13.8% | -27.7% | 36.4% |
| EPS growth (YoY) | 11.8% | 40.9% | 20.8% | 43.9% | 84.2% | 29.6% | -37.9% | -11.9% | -24.9% | 46.3% |
| EPS CAGR (3y) | 21.9% | 8.0% | 5.6% | 9.4% | 19.1% | 0.2% | 13.3% | 6.6% | 26.2% | 42.1% |
| EPS CAGR (5y) | 20.0% | 24.2% | 25.8% | 20.7% | 74.8% | 26.5% | 12.1% | 29.2% | 16.3% | - |
| FCF growth (YoY) | - | - | 14.0% | - | - | 14.6% | - | - | -12.0% | - |
| FCF CAGR (5y) | - | - | 18.5% | - | - | 15.1% | - | - | 17.8% | - |
| Book value growth (YoY) | 45.6% | 16.5% | 40.0% | 39.3% | 29.4% | 19.0% | 15.4% | 15.4% | 42.3% | 108.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Business segments
$12.16B totalSemiconductor Process Control$10.95B · 90.1%
PCBAnd Component Inspection$621.72M · 5.1%
Specialty Semiconductor Process$587.11M · 4.8%
Product / service
$21.63B totalProduct$9.47B · 43.8%
Wafer Inspection$6.20B · 28.7%
Service$2.68B · 12.4%
Patterning$2.20B · 10.2%
Specialty Semiconductor Process$517.20M · 2.4%
PCBAnd Component Inspection$355.89M · 1.6%
Other Revenue$204.60M · 0.9%
Geographic
$12.16B totalCN$4.04B · 33.3%
TW$3.21B · 26.4%
KR$1.45B · 12.0%
North America$1.36B · 11.2%
JP$1.13B · 9.3%
Europe And Israel$574.20M · 4.7%
Rest Of Asia$385.87M · 3.2%
Peer comparison
Same SIC group: Optical Instruments & Lenses
Comparing KLA CORP against the 5 most active filers in the same SIC group.
Dividends
$8.00/share trailing 12 months · +18.5% YoY
| Ex-date | Per share |
|---|---|
| May 18, 2026 | $2.3000 |
| Feb 17, 2026 | $1.9000 |
| Nov 17, 2025 | $1.9000 |
| Aug 18, 2025 | $1.9000 |
| May 19, 2025 | $1.9000 |
| Feb 24, 2025 | $1.7000 |
| Nov 18, 2024 | $1.7000 |
| Aug 15, 2024 | $1.4500 |
| May 14, 2024 | $1.4500 |
| Feb 15, 2024 | $1.4500 |
| Nov 14, 2023 | $1.4500 |
| Aug 14, 2023 | $1.3000 |
| May 12, 2023 | $1.3000 |
| Feb 10, 2023 | $1.3000 |
| Nov 14, 2022 | $1.3000 |
| Aug 12, 2022 | $1.3000 |
| May 13, 2022 | $1.0500 |
| Feb 11, 2022 | $1.0500 |
| Nov 12, 2021 | $1.0500 |
| Aug 13, 2021 | $1.0500 |
| May 14, 2021 | $0.9000 |
| Feb 18, 2021 | $0.9000 |
| Nov 13, 2020 | $0.9000 |
| Aug 14, 2020 | $0.9000 |